Skip to main content
APGE
NASDAQ Life Sciences

$10.9B Acquisition: AbbVie Buys Apogee, Clarifies Lead Drug Phase 3 Timeline

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$132.527
Mkt Cap
$9.993B
52W Low
$34.34
52W High
$133
52W Position info
286% above low
Off High info
at 52W high
Rel. Volume info
32× avg
Market data snapshot near publication time

APGE has more than doubled off its 52-week low of $34.34 on elevated volume (32× avg).

Summary

AbbVie has entered a definitive agreement to acquire Apogee Therapeutics for $135.11 per share in cash, valuing the deal at approximately $10.9 billion. This follows yesterday's SEC filings confirming the acquisition. The news also clarifies that Apogee's lead drug, zumilokibart, is expected to enter Phase 3 later this year, correcting earlier reports that it was already in Phase 3. This acquisition provides a substantial premium for Apogee shareholders, and the updated drug development timeline is a critical detail for assessing the value of the pipeline.

At the time of this announcement, APGE was trading at $132.53 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10B. The 52-week trading range was $34.34 to $133.00. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

APGE - Latest Insights

APGE
Sep 03, 2026, 8:53 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $135.11
Real-time Price: $135.11 info
Change: $0 (0%) info
Market Cap: $10.223B info
APGE
Aug 11, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $134.69
Real-time Price: $135.11 info
Change: +$0.420 (+0.31%) info
Market Cap: $10.223B info
APGE
Aug 10, 2026, 7:52 AM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $134.62
Real-time Price: $135.11 info
Change: +$0.486 (+0.36%) info
Market Cap: $10.223B info
APGE
Aug 10, 2026, 7:19 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $134.79
Real-time Price: $135.11 info
Change: +$0.320 (+0.24%) info
Market Cap: $10.223B info
APGE
Aug 06, 2026, 6:31 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $134.27
Real-time Price: $135.11 info
Change: +$0.840 (+0.63%) info
Market Cap: $10.223B info